Definitions
Sorry, no definitions found. You may find more data at phosphodiesterase.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Phosphodiesterase.
Examples
-
Multum data sheet v • d • e Selective Phosphodiesterase inhibitors | Member Offers close Username: Password: Forgotten your doctor's instructions.
-
E, et al. (2005) Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.
PLoS Biology: New Articles Ting-Ting Hong et al. 2010
-
Heystek HC, Thierry AC, Soulard P, Moulon C (2003) Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.
PLoS ONE Alerts: New Articles Olof Grip et al. 2009
-
All the impotence drugs are included in the one category of the drug named as "Phosphodiesterase Inhibitors."
Press Releases | Press Release Distribution | Submit Press Release 2009
-
Heystek HC, Thierry AC, Soulard P, Moulon C (2003) Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.
-
Phosphodiesterase type-5 (PDE5) inhibitors: sildenafil (Viagra); tadalafil (Cialis); vardenafil (Levitra).
xml's Blinklist.com 2008
-
Interaction of L-Arginine Phosphodiesterase Inhibitors in Vasodilation of the Porcine Internal Mammary Artery We tested the hypothesis that L-arginine (the substrate for nitric oxide production) - combined with amrinone, milrinone (Type III phosphodiesterase [PDE] inhibitors),
xml's Blinklist.com 2008
-
Inhibitors, Hormone Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market
-
Replacement Therapy and Phosphodiesterase Type-5 Inhibitors Will Dominate the Market
-
Orexo AB Announces Phase IIa Data on OX914 in Rhinitis; OX914 Did Not Show a Statistically Significant Reduction in Patient Symptom Scores After Allergen Provocation STOCKHOLM, Sweden -- (BUSINESS WIRE) -- Orexo today reported clinical results from an experimental phase IIa safety and efficacy study in allergic rhinitis with OX914, the first compound in its Phosphodiesterase 4 (PDE4) inhibitor program.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.